首页 > 最新文献

Acta medica academica最新文献

英文 中文
A Hypertrophic Anterior Scalene Muscle and the Passage of a Subclavian Artery Through its Fibres: The Location of Possible Entrapment. 肥大的前斜角肌和锁骨下动脉通过其纤维的通道:可能夹持的位置。
Q3 Medicine Pub Date : 2022-12-01 DOI: 10.5644/ama2006-124.391
George Tsakotos, Vasilios Karampelias, Ilenia Chatziandreou, Dimitrios Philippou, Trifon Totlis, Maria Piagkou

Objective: The presence of cervical ribs, 1st rib anomalies, cervical muscle hypertrophy and repetitive motion are possible aetiologies of subclavian artery (SCA) entrapment and/or compression. Thoracic outlet syndrome of the arterial type may appear with symptoms of hand pain due to the aneurismal part of the compressed SCA. The current cadaveric case describes a hypertrophic right-sided anterior scalene muscle (ASM) and the possible entrapment of the right SCA (RSCA) passing through its fibres. Furthermore, the branching pattern of the entrapped vessel is analysed.

Case report: A hypertrophic ASM was identified in the right infraclavicular area of a male Greek donated cadaver (70 years of age). The RSCA passed through the ASM belly, and some deeply situated fibres extended posteriorly to the RSCA. The ASM compressed the RSCA against the superior part of the 1st rib.

Conclusion: Knowledge of such variants may be important in the diagnosis of upper limb muscle atrophy or neurosensory loss.

目的:颈肋、第一肋骨异常、颈肌肥大和重复运动是锁骨下动脉(SCA)夹陷和/或压迫的可能病因。动脉型胸廓出口综合征可出现由于压迫的SCA的动脉瘤部分而引起的手部疼痛症状。目前的尸体病例描述了肥厚的右侧前斜角肌(ASM)和通过其纤维的右侧SCA (RSCA)可能被困住。此外,还分析了被困血管的分支模式。病例报告:在希腊男性捐献尸体(70岁)的右侧锁骨下区域发现了肥厚的ASM。RSCA穿过ASM腹部,一些位于深部的纤维向后延伸到RSCA。ASM将RSCA压在第一肋骨的上部。结论:了解这些变异可能对上肢肌肉萎缩或神经感觉丧失的诊断有重要意义。
{"title":"A Hypertrophic Anterior Scalene Muscle and the Passage of a Subclavian Artery Through its Fibres: The Location of Possible Entrapment.","authors":"George Tsakotos,&nbsp;Vasilios Karampelias,&nbsp;Ilenia Chatziandreou,&nbsp;Dimitrios Philippou,&nbsp;Trifon Totlis,&nbsp;Maria Piagkou","doi":"10.5644/ama2006-124.391","DOIUrl":"https://doi.org/10.5644/ama2006-124.391","url":null,"abstract":"<p><strong>Objective: </strong>The presence of cervical ribs, 1st rib anomalies, cervical muscle hypertrophy and repetitive motion are possible aetiologies of subclavian artery (SCA) entrapment and/or compression. Thoracic outlet syndrome of the arterial type may appear with symptoms of hand pain due to the aneurismal part of the compressed SCA. The current cadaveric case describes a hypertrophic right-sided anterior scalene muscle (ASM) and the possible entrapment of the right SCA (RSCA) passing through its fibres. Furthermore, the branching pattern of the entrapped vessel is analysed.</p><p><strong>Case report: </strong>A hypertrophic ASM was identified in the right infraclavicular area of a male Greek donated cadaver (70 years of age). The RSCA passed through the ASM belly, and some deeply situated fibres extended posteriorly to the RSCA. The ASM compressed the RSCA against the superior part of the 1st rib.</p><p><strong>Conclusion: </strong>Knowledge of such variants may be important in the diagnosis of upper limb muscle atrophy or neurosensory loss.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"51 3","pages":"212-216"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7a/bd/AMA-51-212.PMC10116174.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9389034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Superficial Temporal Artery: Anatomy and Clinical Significance in the Era of Facial Surgery and Aesthetic Medicine. 颞浅动脉:在面部外科和美容医学时代的解剖和临床意义。
Q3 Medicine Pub Date : 2022-12-01 DOI: 10.5644/ama2006-124.393
Dimitra Daskalopoulou, Alkis Matsas, Dimosthenis Chrysikos, Theodore Troupis

Objective: The aim of this review was to present the vascular pattern of the STA, as well as anatomical variations, and to accentuate the areas which should be taken into consideration during manipulations along the course of the artery.

Background: The STA may be encountered during several aesthetic procedures on the face, and iatrogenic trauma could be an incriminating factor of diverse sequelae. The constant increase in demand for facial aesthetic procedures has rendered it imperative to maximize safety and patient satisfaction.

Methods: We conducted a narrative literature review using the electronic databases of PubMed and Google Scholar, retrieving studies concerning the anatomy and variations of the STA. Moreover, we identified registered clinical cases presenting complications which involved the artery.

Discussion: The anatomic morphology of the STA is described and classification systems summarized, on the basis of the studies retrieved. In addition, the STA is related to defined landmarks, and specific danger zones are emphasized. Finally, the clinical significance of the artery is reflected in registered cases of adverse events following specific aesthetic surgeries.

Conclusion: Thorough knowledge of the anatomical variability of the STA, and awareness of the danger zones involved in aesthetic procedures, combined with intraoperative vigilance could increase safety and minimize the advent of relevant sequelae.

目的:本综述的目的是介绍STA的血管模式,以及解剖变异,并强调在沿着动脉的过程中操作时应考虑的区域。背景:在许多面部美容手术中可能会遇到STA,医源性创伤可能是各种后遗症的罪魁祸首。对面部美容手术的需求不断增加,使得最大限度地提高安全性和患者满意度势在必行。方法:我们使用PubMed和Google Scholar的电子数据库进行叙述性文献综述,检索有关STA解剖和变异的研究。此外,我们还发现了出现累及动脉的并发症的临床病例。讨论:根据检索到的研究,描述了STA的解剖形态并总结了分类系统。此外,STA与已定义的地标相关,并强调特定的危险区域。最后,动脉的临床意义反映在特定美容手术后不良事件的登记病例中。结论:充分了解STA的解剖变异性,了解美容手术中涉及的危险区域,并结合术中警惕,可以提高安全性,最大限度地减少相关后遗症的出现。
{"title":"The Superficial Temporal Artery: Anatomy and Clinical Significance in the Era of Facial Surgery and Aesthetic Medicine.","authors":"Dimitra Daskalopoulou,&nbsp;Alkis Matsas,&nbsp;Dimosthenis Chrysikos,&nbsp;Theodore Troupis","doi":"10.5644/ama2006-124.393","DOIUrl":"https://doi.org/10.5644/ama2006-124.393","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this review was to present the vascular pattern of the STA, as well as anatomical variations, and to accentuate the areas which should be taken into consideration during manipulations along the course of the artery.</p><p><strong>Background: </strong>The STA may be encountered during several aesthetic procedures on the face, and iatrogenic trauma could be an incriminating factor of diverse sequelae. The constant increase in demand for facial aesthetic procedures has rendered it imperative to maximize safety and patient satisfaction.</p><p><strong>Methods: </strong>We conducted a narrative literature review using the electronic databases of PubMed and Google Scholar, retrieving studies concerning the anatomy and variations of the STA. Moreover, we identified registered clinical cases presenting complications which involved the artery.</p><p><strong>Discussion: </strong>The anatomic morphology of the STA is described and classification systems summarized, on the basis of the studies retrieved. In addition, the STA is related to defined landmarks, and specific danger zones are emphasized. Finally, the clinical significance of the artery is reflected in registered cases of adverse events following specific aesthetic surgeries.</p><p><strong>Conclusion: </strong>Thorough knowledge of the anatomical variability of the STA, and awareness of the danger zones involved in aesthetic procedures, combined with intraoperative vigilance could increase safety and minimize the advent of relevant sequelae.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"51 3","pages":"232-242"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/76/bc/AMA-51-232.PMC10116177.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9389038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High Flow Nasal Cannula Versus Noninvasive Positive Pressure Ventilation as Initial Respiratory Support in Patients with Chronic Obstructive Pulmonary Disease and Covid-19: Exploratory Analysis in Two Intensive Care Units. 高流量鼻插管与无创正压通气作为慢性阻塞性肺疾病和Covid-19患者的初始呼吸支持:两个重症监护病房的探索性分析
Q3 Medicine Pub Date : 2022-12-01 DOI: 10.5644/ama2006-124.389
Aida Mujaković, Tijana Kovačević, Edin Begić, Almir Fajkić, Goran Barić, Anida Jamakosmanović, Nermin Ismić, Peđa Kovačević

Objective: To identify the type of the non-invasive ventilatory treatment for patients diagnosed with chronic obstructive pulmonary disease (COPD), with respiratory status deteriorated by COVID-19 pneumonia, and in need of treatment in the Intensive Care Unit (ICU).

Materials and methods: This cross-sectional study was conducted over a one-year period in the medical intensive care units of two hospitals. As the patients' clinical condition deteriorated and the parameters of the arterial blood gas (ABG) analysis worsened, oxygen support was applied via a high flow nasal cannula (HFNC) or by non-invasive positive pressure ventilation (NPPV). According to the control values of the arterial oxygen saturation (SaO2) and the parameters of ABG, the patients were enabled to be transferred between the two types of non-invasive ventilatory support. The primary outcome was the length of hospital stay, while secondary outcomes were the rate of intubation, the mortality rate, and respiratory supportfree days.

Results: Out of 21 critical patients with COPD and COVID-19, 11 (52.4%) were initially treated with NPPV and 10 (47.6%) with HFNC. The ages (67±9.79 in NPPV group vs. 70.10±10.25 in HFNC group) and severity of illness (SOFA score 5 (3.5) in NPPV group vs. 5 (2.8) in HFNC group) were similar between the two groups. Switching the mode of respiratory support was more common in NPPV (58.3% in survivor group vs. 41.7% in non-survivor group). Patients treated with NPPV compared to HFNC had a nominally longer length of stay (15 (11) vs. 11.5 (4.25)), and higher risk of intubation (66.7% vs. 33.3%) and mortality (66.7% vs. 33.3%), but the comparisons did not reach statistical significance. Survivors had significantly longer Medical Intensive Care Unit and hospital stays, but significantly lower FiO2 (0.60 vs.1) and higher values of PaO2/FiO2 (78(32.4) vs. 56.3(17.8)) than non-survivors. All patients were treated with corticosteroids, and the duration of treatment was similar between groups.

Conclusion: In critically ill patients with COPD and COVID-19, both HFNC and NPPV were commonly used as the initial mode of ventilation. Switching to a different mode and adverse patient outcomes were more frequent in patients initially treated with NPPV. Survivors had higher values of PaO2/FiO2 than non-survivors.

目的:探讨诊断为慢性阻塞性肺疾病(COPD)、COVID-19肺炎导致呼吸状况恶化、需要重症监护病房(ICU)治疗的患者的无创通气治疗类型。材料和方法:本横断面研究在两家医院的医学重症监护室进行了为期一年的研究。随着患者临床病情恶化,动脉血气(ABG)分析参数恶化,采用高流量鼻插管(HFNC)或无创正压通气(NPPV)给予氧支持。根据动脉血氧饱和度(SaO2)的控制值和ABG的参数,使患者能够在两种无创通气支持之间切换。主要结局是住院时间,次要结局是插管率、死亡率和无呼吸支持天数。结果:21例COPD合并COVID-19危重患者中,11例(52.4%)采用NPPV初始治疗,10例(47.6%)采用HFNC初始治疗。两组患者的年龄(NPPV组为67±9.79,HFNC组为70.10±10.25)和病情严重程度(SOFA评分为5分(3.5),HFNC组为5分(2.8))比较,差异无统计学意义。切换呼吸支持模式在NPPV中更为常见(生存组为58.3%,非生存组为41.7%)。与HFNC相比,NPPV治疗的患者名义上住院时间更长(15(11)比11.5(4.25)),插管风险(66.7%比33.3%)和死亡率(66.7%比33.3%)更高,但比较无统计学意义。与非幸存者相比,幸存者的医疗重症监护病房和住院时间明显更长,但FiO2明显较低(0.60 vs.1), PaO2/FiO2值明显较高(78(32.4)vs 56.3(17.8))。所有患者均接受皮质类固醇治疗,治疗时间组间相似。结论:在COPD合并COVID-19危重患者中,HFNC和NPPV均可作为初始通气模式。在最初接受NPPV治疗的患者中,切换到不同的模式和不良患者结果更常见。幸存者的PaO2/FiO2值高于非幸存者。
{"title":"High Flow Nasal Cannula Versus Noninvasive Positive Pressure Ventilation as Initial Respiratory Support in Patients with Chronic Obstructive Pulmonary Disease and Covid-19: Exploratory Analysis in Two Intensive Care Units.","authors":"Aida Mujaković,&nbsp;Tijana Kovačević,&nbsp;Edin Begić,&nbsp;Almir Fajkić,&nbsp;Goran Barić,&nbsp;Anida Jamakosmanović,&nbsp;Nermin Ismić,&nbsp;Peđa Kovačević","doi":"10.5644/ama2006-124.389","DOIUrl":"https://doi.org/10.5644/ama2006-124.389","url":null,"abstract":"<p><strong>Objective: </strong>To identify the type of the non-invasive ventilatory treatment for patients diagnosed with chronic obstructive pulmonary disease (COPD), with respiratory status deteriorated by COVID-19 pneumonia, and in need of treatment in the Intensive Care Unit (ICU).</p><p><strong>Materials and methods: </strong>This cross-sectional study was conducted over a one-year period in the medical intensive care units of two hospitals. As the patients' clinical condition deteriorated and the parameters of the arterial blood gas (ABG) analysis worsened, oxygen support was applied via a high flow nasal cannula (HFNC) or by non-invasive positive pressure ventilation (NPPV). According to the control values of the arterial oxygen saturation (SaO2) and the parameters of ABG, the patients were enabled to be transferred between the two types of non-invasive ventilatory support. The primary outcome was the length of hospital stay, while secondary outcomes were the rate of intubation, the mortality rate, and respiratory supportfree days.</p><p><strong>Results: </strong>Out of 21 critical patients with COPD and COVID-19, 11 (52.4%) were initially treated with NPPV and 10 (47.6%) with HFNC. The ages (67±9.79 in NPPV group vs. 70.10±10.25 in HFNC group) and severity of illness (SOFA score 5 (3.5) in NPPV group vs. 5 (2.8) in HFNC group) were similar between the two groups. Switching the mode of respiratory support was more common in NPPV (58.3% in survivor group vs. 41.7% in non-survivor group). Patients treated with NPPV compared to HFNC had a nominally longer length of stay (15 (11) vs. 11.5 (4.25)), and higher risk of intubation (66.7% vs. 33.3%) and mortality (66.7% vs. 33.3%), but the comparisons did not reach statistical significance. Survivors had significantly longer Medical Intensive Care Unit and hospital stays, but significantly lower FiO2 (0.60 vs.1) and higher values of PaO2/FiO2 (78(32.4) vs. 56.3(17.8)) than non-survivors. All patients were treated with corticosteroids, and the duration of treatment was similar between groups.</p><p><strong>Conclusion: </strong>In critically ill patients with COPD and COVID-19, both HFNC and NPPV were commonly used as the initial mode of ventilation. Switching to a different mode and adverse patient outcomes were more frequent in patients initially treated with NPPV. Survivors had higher values of PaO2/FiO2 than non-survivors.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"51 3","pages":"199-208"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/47/6f/AMA-51-199.PMC10116172.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9688433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Efficacy and Tolerability of a Fixed Combination of Perindopril and Indapamide in the Treatment of Unregulated Essential Hypertension - a Postmarketing Study. 培哚普利和吲达帕胺固定联合治疗非调节高血压的疗效和耐受性——上市后研究
Q3 Medicine Pub Date : 2022-12-01 DOI: 10.5644/ama2006-124.385
Aziz Šukalo, Jasna Džananović Jaganjac, Amna Tanović Avdić, Una Glamočlija, Željka Popović, Alis Boloban, Merita Tirić Čampara, Meliha Mehić

Objective: The objective of this non-interventional post-marketing clinical trial was to analyze the antihypertensive effect and safety of a fixed combination of perindopril and indapamide in the treatment of unregulated essential hypertension.

Patients and methods: The prospective clinical trial included patients aged 20 to 75 years with essential hypertension and blood pressure values ≥ 140/90 mmHg at baseline. On the basis of the investigator's decision, patients received 2 mg perindopril + 0.625 mg indapamide (group 2+0.625) or 4 mg perindopril + 1.25 mg indapamide (group 4+1.25).

Results: The study included 1173 patients (426 patients in group 2+0.625 and 747 patients in group 4+1.25) at 27 investigational centers in Bosnia and Herzegovina. Mean blood pressure values at baseline and visits after nine months were significantly higher in the 4+1.25 group compared to the 2+0.625 group. There was a significant drop in systolic and diastolic blood pressure in both groups. The target values of systolic and diastolic blood pressure, according to the European Society of Cardiology (2018), were reached after nine months of therapy by more than 80% of patients in the 2+0.625 group, and this number was significantly higher compared to the 4+1.25 group where more than 60% of patients reached target values. Newly diagnosed patients had a better response to therapy. The percentage of patients receiving additional antihypertensive therapy decreased by the end of the study. Age, gender and the existence of diabetes mellitus were identified as negative predictors of target blood pressure achievement. The therapy showed a good safety profile.

Conclusion: A fixed combination of perindopril and indapamide was effective and safe in the treatment of unregulated essential hypertension.

目的:本非介入性上市后临床试验的目的是分析培哚普利与吲达帕胺固定联合治疗非调节型原发性高血压的降压效果和安全性。患者和方法:前瞻性临床试验纳入20 - 75岁原发性高血压患者,基线血压≥140/90 mmHg。根据研究者的决定,患者接受2 mg培哚普利+0.625 mg吲达帕胺(2组+0.625)或4 mg培哚普利+1.25 mg吲达帕胺(4组+1.25)。结果:该研究纳入了波斯尼亚和黑塞哥维那27个研究中心的1173例患者(2+0.625组426例,4+1.25组747例)。与2+0.625组相比,4+1.25组的基线和9个月后就诊的平均血压值显着高于2+0.625组。两组患者的收缩压和舒张压均有明显下降。根据欧洲心脏病学会(2018)的数据,2+0.625组超过80%的患者在治疗9个月后达到了收缩压和舒张压的目标值,这一数字明显高于4+1.25组,超过60%的患者达到了目标值。新诊断的患者对治疗有更好的反应。在研究结束时,接受额外抗高血压治疗的患者比例下降。年龄、性别和是否患有糖尿病被认为是达到目标血压的负面预测因素。该疗法显示出良好的安全性。结论:培哚普利与吲达帕胺固定联合治疗非调节型原发性高血压有效、安全。
{"title":"The Efficacy and Tolerability of a Fixed Combination of Perindopril and Indapamide in the Treatment of Unregulated Essential Hypertension - a Postmarketing Study.","authors":"Aziz Šukalo,&nbsp;Jasna Džananović Jaganjac,&nbsp;Amna Tanović Avdić,&nbsp;Una Glamočlija,&nbsp;Željka Popović,&nbsp;Alis Boloban,&nbsp;Merita Tirić Čampara,&nbsp;Meliha Mehić","doi":"10.5644/ama2006-124.385","DOIUrl":"https://doi.org/10.5644/ama2006-124.385","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this non-interventional post-marketing clinical trial was to analyze the antihypertensive effect and safety of a fixed combination of perindopril and indapamide in the treatment of unregulated essential hypertension.</p><p><strong>Patients and methods: </strong>The prospective clinical trial included patients aged 20 to 75 years with essential hypertension and blood pressure values ≥ 140/90 mmHg at baseline. On the basis of the investigator's decision, patients received 2 mg perindopril + 0.625 mg indapamide (group 2+0.625) or 4 mg perindopril + 1.25 mg indapamide (group 4+1.25).</p><p><strong>Results: </strong>The study included 1173 patients (426 patients in group 2+0.625 and 747 patients in group 4+1.25) at 27 investigational centers in Bosnia and Herzegovina. Mean blood pressure values at baseline and visits after nine months were significantly higher in the 4+1.25 group compared to the 2+0.625 group. There was a significant drop in systolic and diastolic blood pressure in both groups. The target values of systolic and diastolic blood pressure, according to the European Society of Cardiology (2018), were reached after nine months of therapy by more than 80% of patients in the 2+0.625 group, and this number was significantly higher compared to the 4+1.25 group where more than 60% of patients reached target values. Newly diagnosed patients had a better response to therapy. The percentage of patients receiving additional antihypertensive therapy decreased by the end of the study. Age, gender and the existence of diabetes mellitus were identified as negative predictors of target blood pressure achievement. The therapy showed a good safety profile.</p><p><strong>Conclusion: </strong>A fixed combination of perindopril and indapamide was effective and safe in the treatment of unregulated essential hypertension.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"51 3","pages":"163-174"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9a/b1/AMA-51-163.PMC10116171.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9688434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation and the Reliability of the ACIC Questionnaire in the Primary Health Care Setting: a Study from Bosnia and Herzegovina. 初级卫生保健机构ACIC问卷的有效性和信度:来自波斯尼亚和黑塞哥维那的研究。
Q3 Medicine Pub Date : 2022-12-01 DOI: 10.5644/ama2006-124.387
Natasa Pilipovic-Broceta, Nadja Vasiljevic, Nevena Todorovic, Maja Racic

Objective: The aim of this study was to carry out the cultural adaptation and validation of the Assessment of Chronic Illness Care questionnaire (ACIC) in the Republika Srpska, Bosnia and Herzegovina.

Methods: A validation study was conducted in two randomly selected primary health care centers in the Republika Srpska, Bosnia and Herzegovina, during March and April 2016. The study participants were all physicians working in family medicine departments during the study. Translation of the ACIC questionnaire version 3.5 was performed following the guidelines of the World Health Organization. The validity and reliability of the questionnaire were tested with face validity, construct validity, and internal consistency.

Results: The questionnaire was distributed to 66 family physicians. Missing values were negligible, therefore the criteria for factor analysis were met. Exploratory factor analysis confirmed that the questionnaire measured one factor. The Cronbach alpha coefficient (0.970) showed the excellent level of internal consistency of the questionnaire. The intraclass correlation coefficient (0.802) confirmed the good reliability of the questionnaire.

Conclusion: The ACIC questionnaire can be used to assess the quality of chronic care in family medicine practice in Bosnia and Herzegovina. Further research is needed to explore how changes in healthcare care delivery impact changes in the Chronic Care Model domain.

目的:本研究的目的是在波斯尼亚和黑塞哥维那共和国进行慢性疾病护理评估问卷(ACIC)的文化适应和验证。方法:于2016年3月至4月在波斯尼亚和黑塞哥维那共和国斯普斯卡共和国的两个随机选择的初级卫生保健中心进行验证研究。研究参与者都是在研究期间在家庭医学部门工作的医生。根据世界卫生组织的指导方针翻译了ACIC调查表3.5版。采用面效度、结构效度和内部一致性对问卷的效度和信度进行检验。结果:共向66名家庭医生发放问卷。缺失值可以忽略不计,因此符合因子分析的标准。探索性因素分析证实,问卷测量了一个因素。Cronbach α系数(0.970)表明问卷具有优异的内部一致性。类内相关系数为0.802,证实问卷具有良好的信度。结论:ACIC问卷可用于评价波黑家庭医学慢性护理质量。需要进一步的研究来探索医疗保健服务的变化如何影响慢性护理模型领域的变化。
{"title":"Validation and the Reliability of the ACIC Questionnaire in the Primary Health Care Setting: a Study from Bosnia and Herzegovina.","authors":"Natasa Pilipovic-Broceta,&nbsp;Nadja Vasiljevic,&nbsp;Nevena Todorovic,&nbsp;Maja Racic","doi":"10.5644/ama2006-124.387","DOIUrl":"https://doi.org/10.5644/ama2006-124.387","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to carry out the cultural adaptation and validation of the Assessment of Chronic Illness Care questionnaire (ACIC) in the Republika Srpska, Bosnia and Herzegovina.</p><p><strong>Methods: </strong>A validation study was conducted in two randomly selected primary health care centers in the Republika Srpska, Bosnia and Herzegovina, during March and April 2016. The study participants were all physicians working in family medicine departments during the study. Translation of the ACIC questionnaire version 3.5 was performed following the guidelines of the World Health Organization. The validity and reliability of the questionnaire were tested with face validity, construct validity, and internal consistency.</p><p><strong>Results: </strong>The questionnaire was distributed to 66 family physicians. Missing values were negligible, therefore the criteria for factor analysis were met. Exploratory factor analysis confirmed that the questionnaire measured one factor. The Cronbach alpha coefficient (0.970) showed the excellent level of internal consistency of the questionnaire. The intraclass correlation coefficient (0.802) confirmed the good reliability of the questionnaire.</p><p><strong>Conclusion: </strong>The ACIC questionnaire can be used to assess the quality of chronic care in family medicine practice in Bosnia and Herzegovina. Further research is needed to explore how changes in healthcare care delivery impact changes in the Chronic Care Model domain.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"51 3","pages":"181-188"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8c/a8/AMA-51-181.PMC10116173.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9389033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopıc Anatomy of the Lacrımal Sac: A Cadaverıc Study. Endoscopıc Lacrımal囊的解剖:Cadaverıc研究。
Q3 Medicine Pub Date : 2022-12-01 DOI: 10.5644/ama2006-124.386
Rukiye Ozcelik Erdem, Mehmet Akif Dundar, Senanur Arbag, Hamdi Arbag, Muzaffer Seker

Objective: To describe the anatomy of the lacrimal sac in relation to the lateral nasal wall by cadaver dissection, and to measure the distances of surgically important landmarks from relevant structures for safer and more efficient surgery.

Method: A total of 12 endoscopic dacryocystorhinostomy (DCR) were performed on both sides (right and left) of 6 fresh-frozen cadavers. The distances of the lacrimal sac to the posterior edge of the uncinate process, the frontal process of the maxilla, the maxillary ostium, the nasal vestibule, the middle turbinate attachment and the inferior turbinate were measured. In addition, the width and length of the lacrimal sac were measured.

Results: The mean width and length of the lacrimal sac were 5.6 mm and 11.1 mm, respectively. The lacrimal sac was located at 15.2 mm from the posterior edge of the uncinate process, at 35.5 mm from the nasal vestibule, at 13.5 mm from the maxillary ostium, at 12.2 mm from the frontal process of the maxilla, at 8.7 mm from the middle turbinate attachment, and at 7.3 mm from the inferior turbinate.

Conclusion: This study provides additional measurements regarding the lacrimal sac and its relationships with nearby landmarks for use in endoscopic dacryocystorhinostomy. The distances of the lacrimal sac to the nasal vestibule, the uncinate process and the frontal process of the maxilla are not as reliable as the middle turbinate attachment for predicting the anatomic localization of the lacrimal sac during DCR.

目的:通过尸体解剖描述泪囊与鼻外壁的解剖关系,并测量手术重要标志与相关结构的距离,以便更安全、更有效地进行手术。方法:对6具新鲜冷冻尸体分别行12例左右两侧泪囊鼻腔造口术(DCR)。测量泪囊到钩突后缘、上颌额突、上颌口、鼻前庭、中鼻甲附着体和下鼻甲的距离。测量泪囊的宽度和长度。结果:泪囊平均宽度为5.6 mm,长度为11.1 mm。泪囊位于距钩突后缘15.2 mm,距鼻前庭35.5 mm,距上颌口13.5 mm,距上颌骨额突12.2 mm,距中鼻甲附着体8.7 mm,距下鼻甲7.3 mm。结论:本研究为内窥镜泪囊造口术中泪囊及其与附近标志的关系提供了额外的测量方法。泪囊到鼻前庭、钩突和上颌骨额突的距离在预测DCR时泪囊的解剖定位上不如中鼻甲附着体可靠。
{"title":"Endoscopıc Anatomy of the Lacrımal Sac: A Cadaverıc Study.","authors":"Rukiye Ozcelik Erdem,&nbsp;Mehmet Akif Dundar,&nbsp;Senanur Arbag,&nbsp;Hamdi Arbag,&nbsp;Muzaffer Seker","doi":"10.5644/ama2006-124.386","DOIUrl":"https://doi.org/10.5644/ama2006-124.386","url":null,"abstract":"<p><strong>Objective: </strong>To describe the anatomy of the lacrimal sac in relation to the lateral nasal wall by cadaver dissection, and to measure the distances of surgically important landmarks from relevant structures for safer and more efficient surgery.</p><p><strong>Method: </strong>A total of 12 endoscopic dacryocystorhinostomy (DCR) were performed on both sides (right and left) of 6 fresh-frozen cadavers. The distances of the lacrimal sac to the posterior edge of the uncinate process, the frontal process of the maxilla, the maxillary ostium, the nasal vestibule, the middle turbinate attachment and the inferior turbinate were measured. In addition, the width and length of the lacrimal sac were measured.</p><p><strong>Results: </strong>The mean width and length of the lacrimal sac were 5.6 mm and 11.1 mm, respectively. The lacrimal sac was located at 15.2 mm from the posterior edge of the uncinate process, at 35.5 mm from the nasal vestibule, at 13.5 mm from the maxillary ostium, at 12.2 mm from the frontal process of the maxilla, at 8.7 mm from the middle turbinate attachment, and at 7.3 mm from the inferior turbinate.</p><p><strong>Conclusion: </strong>This study provides additional measurements regarding the lacrimal sac and its relationships with nearby landmarks for use in endoscopic dacryocystorhinostomy. The distances of the lacrimal sac to the nasal vestibule, the uncinate process and the frontal process of the maxilla are not as reliable as the middle turbinate attachment for predicting the anatomic localization of the lacrimal sac during DCR.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"51 3","pages":"175-180"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4b/fa/AMA-51-175.PMC10116169.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10295781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group. 肿瘤类型不可知,靶向治疗:BRAF抑制剂加入该组。
Q3 Medicine Pub Date : 2022-12-01 DOI: 10.5644/ama2006-124.392
Semir Vranic, Gargi D Basu, David W Hall, Zoran Gatalica

In the present review, we briefly discuss the breakthrough advances in precision medicine using a tumor-agnostic approach and focus on BRAF treatment modalities, the mechanisms of resistance and the diagnostic approach in cancers with BRAF mutations. Tumor-type agnostic drug therapies work across cancer types and present a significant novel shift in precision cancer medicine. They are the consequence of carefully designed clinical trials that showed the value of tumor biomarkers, not just in diagnosis but in therapy guidance. Six tumor-agnostic drugs (with seven indications) have been approved through October 2022 by FDA. The first tumor-agnostic treatment modality was pembrolizumab for MSI-H/dMMR solid tumors, approved in 2017. This was followed by approvals of larotrectinib and entrectinib for cancers with NTRK fusions without a known acquired resistance mutation. In 2020, pembrolizumab was approved for all TMB-high solid cancers, while a PD-L1 inhibitor dostarlimab-gxly was approved for dMMR solid cancers in 2021. A combination of BRAF/MEK inhibitors (dabrafenib/trametinib) was approved as a tumor-agnostic therapy in June 2022 for all histologic types of solid metastatic cancers harboring BRAFV600E mutations. In September 2022, RET inhibitor selpercatinib was approved for solid cancers with RET gene fusions. CONCLUSION: Precision cancer medicine has substantially improved cancer diagnostics and treatment. Tissue type-agnostic drug therapies present a novel shift in precision cancer medicine. This approach rapidly expands to provide treatments for patients with different cancers harboring the same molecular alteration.

在本文中,我们简要讨论了基于肿瘤不确定方法的精准医学的突破性进展,并重点讨论了BRAF突变癌症的治疗方式、耐药机制和诊断方法。肿瘤类型不可知的药物治疗在不同类型的癌症中起作用,并在精准癌症医学中呈现出重大的新转变。它们是精心设计的临床试验的结果,这些试验显示了肿瘤生物标志物的价值,不仅在诊断方面,而且在治疗指导方面。截至2022年10月,FDA已批准6种肿瘤不可知药物(7种适应症)。首个肿瘤不确定治疗方式是pembrolizumab用于MSI-H/dMMR实体瘤,于2017年获批。随后,larorectinib和entrectinib被批准用于无已知获得性耐药突变的NTRK融合癌症。2020年,派姆单抗被批准用于所有tmb -高实体癌,而PD-L1抑制剂dostarlimab-gxly于2021年被批准用于dMMR实体癌。BRAF/MEK抑制剂组合(dabrafenib/trametinib)于2022年6月被批准为肿瘤不确定疗法,用于所有组织学类型的BRAFV600E突变的实体转移性癌症。2022年9月,RET抑制剂selpercatinib被批准用于RET基因融合的实体癌。结论:精准癌症医学大大提高了癌症的诊断和治疗水平。组织类型不可知的药物治疗提出了精确癌症医学的新转变。这种方法迅速扩展到为具有相同分子变异的不同癌症患者提供治疗。
{"title":"Tumor-Type Agnostic, Targeted Therapies: BRAF Inhibitors Join the Group.","authors":"Semir Vranic,&nbsp;Gargi D Basu,&nbsp;David W Hall,&nbsp;Zoran Gatalica","doi":"10.5644/ama2006-124.392","DOIUrl":"https://doi.org/10.5644/ama2006-124.392","url":null,"abstract":"<p><p>In the present review, we briefly discuss the breakthrough advances in precision medicine using a tumor-agnostic approach and focus on BRAF treatment modalities, the mechanisms of resistance and the diagnostic approach in cancers with BRAF mutations. Tumor-type agnostic drug therapies work across cancer types and present a significant novel shift in precision cancer medicine. They are the consequence of carefully designed clinical trials that showed the value of tumor biomarkers, not just in diagnosis but in therapy guidance. Six tumor-agnostic drugs (with seven indications) have been approved through October 2022 by FDA. The first tumor-agnostic treatment modality was pembrolizumab for MSI-H/dMMR solid tumors, approved in 2017. This was followed by approvals of larotrectinib and entrectinib for cancers with NTRK fusions without a known acquired resistance mutation. In 2020, pembrolizumab was approved for all TMB-high solid cancers, while a PD-L1 inhibitor dostarlimab-gxly was approved for dMMR solid cancers in 2021. A combination of BRAF/MEK inhibitors (dabrafenib/trametinib) was approved as a tumor-agnostic therapy in June 2022 for all histologic types of solid metastatic cancers harboring BRAFV600E mutations. In September 2022, RET inhibitor selpercatinib was approved for solid cancers with RET gene fusions. CONCLUSION: Precision cancer medicine has substantially improved cancer diagnostics and treatment. Tissue type-agnostic drug therapies present a novel shift in precision cancer medicine. This approach rapidly expands to provide treatments for patients with different cancers harboring the same molecular alteration.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"51 3","pages":"217-231"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cd/18/AMA-51-217.PMC10116180.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9389037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Prevalence and Morphometry of the Atlas Vertebra Retrotransverse Foramen. 寰椎横后孔的流行及形态测定。
Q3 Medicine Pub Date : 2022-12-01 DOI: 10.5644/ama2006-124.388
Christos Lyrtzis, George Tsakotos, Michael Kostares, Maria Piagkou, Chrysovalantis Mariorakis, Konstantinos Natsis

Objective: The current study records the prevalence of the accessory foramen, located posterior to the transverse foramen (TF), the so-called the retrotransverse foramen (RTF), its morphometry, exact location, and coexistence with ossified posterior bridges. Additionally, factors associated with the length of the RTF are investigated.

Materials: One-hundred and forty-one dried atlas vertebrae were examined.

Results: Thirty-seven out of the 141 vertebrae (26.2%) had at least one RTF. The RTF was unilateral in 67.6% and bilateral in 32.4%. The mean RTF anteroposterior diameter (length) was 4.2±1.4 mm on the right and 3.8±1.0 mm on the left side. The mean RTF laterolateral diameter (width) was 2.6±1.2 mm on the right and 2.5±0.8 mm on the left side. Both dimensions were symmetrical. The RTF was symmetrically located from the TF, at a mean distance of 4.6±1.1 mm on the right and of 4.5±0.9 mm on the left side. For the given TF-RTF distance, laterality, and presence of posterior bridges, each mm increase in the RTF width was associated with a 0.74 mm increase in the relevant length.

Conclusion: The estimated prevalence was higher than most of those reported in other studies. However, the between-studies prevalence varies to a significant degree. Hence, a systematic review and meta-analysis should be performed to identify a more precise estimate due to the clinical importance of the RTF.

目的:本研究记录了位于横孔(TF)后方的副孔(即所谓的后横孔(RTF))的流行情况、其形态、确切位置以及与骨化后桥的共存情况。此外,研究了与RTF长度相关的因素。材料:研究了141块干椎体。结果:141个椎体中有37个(26.2%)至少有一个RTF。单侧RTF占67.6%,双侧RTF占32.4%。右侧RTF前后径(长度)平均为4.2±1.4 mm,左侧RTF前后径(长度)平均为3.8±1.0 mm。右侧RTF外侧直径(宽度)平均为2.6±1.2 mm,左侧RTF外侧直径(宽度)平均为2.5±0.8 mm。两个维度都是对称的。RTF与TF对称分布,右侧平均距离4.6±1.1 mm,左侧平均距离4.5±0.9 mm。对于给定的TF-RTF距离、侧度和存在后桥,RTF宽度每增加mm,相关长度增加0.74 mm。结论:估计患病率高于大多数其他研究报告。然而,研究之间的患病率差异很大。因此,由于RTF的临床重要性,应该进行系统回顾和荟萃分析,以确定更精确的估计。
{"title":"The Prevalence and Morphometry of the Atlas Vertebra Retrotransverse Foramen.","authors":"Christos Lyrtzis,&nbsp;George Tsakotos,&nbsp;Michael Kostares,&nbsp;Maria Piagkou,&nbsp;Chrysovalantis Mariorakis,&nbsp;Konstantinos Natsis","doi":"10.5644/ama2006-124.388","DOIUrl":"https://doi.org/10.5644/ama2006-124.388","url":null,"abstract":"<p><strong>Objective: </strong>The current study records the prevalence of the accessory foramen, located posterior to the transverse foramen (TF), the so-called the retrotransverse foramen (RTF), its morphometry, exact location, and coexistence with ossified posterior bridges. Additionally, factors associated with the length of the RTF are investigated.</p><p><strong>Materials: </strong>One-hundred and forty-one dried atlas vertebrae were examined.</p><p><strong>Results: </strong>Thirty-seven out of the 141 vertebrae (26.2%) had at least one RTF. The RTF was unilateral in 67.6% and bilateral in 32.4%. The mean RTF anteroposterior diameter (length) was 4.2±1.4 mm on the right and 3.8±1.0 mm on the left side. The mean RTF laterolateral diameter (width) was 2.6±1.2 mm on the right and 2.5±0.8 mm on the left side. Both dimensions were symmetrical. The RTF was symmetrically located from the TF, at a mean distance of 4.6±1.1 mm on the right and of 4.5±0.9 mm on the left side. For the given TF-RTF distance, laterality, and presence of posterior bridges, each mm increase in the RTF width was associated with a 0.74 mm increase in the relevant length.</p><p><strong>Conclusion: </strong>The estimated prevalence was higher than most of those reported in other studies. However, the between-studies prevalence varies to a significant degree. Hence, a systematic review and meta-analysis should be performed to identify a more precise estimate due to the clinical importance of the RTF.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"51 3","pages":"189-198"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/54/40/AMA-51-189.PMC10116178.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9389032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anatomical Variations of Vascular Anatomy in Meckel's Diverticulum. 梅克尔憩室血管解剖的解剖学变异。
Q3 Medicine Pub Date : 2022-12-01 DOI: 10.5644/ama2006-124.394
Dimitrios Malligiannis Ntalianis, Rami N Maloula, Konstantinos Malligiannis Ntalianis, Panagiotis Giavopoulos, Eirini Solia, Dimosthenis Chrysikos, Vasileios Karampelias, Theodore Troupis

Objective: The objective of the current study was to describe the anatomical variations of vessels observed in patients with Meckel's Diverticulum.

Methods: A narrative review of the literature was undertaken by means of the PubMed database, using the terms: "Meckel's Diverticulum AND vessels", "Meckel's Diverticulum AND anatomical variation" and "Meckel's Diverticulum variation". Classical anatomical textbooks were also used for normal anatomy. Additional articles provided useful information in relation to the aim of this review. Hence, the articles that met the inclusion criteria were included in this review, and the collected data were categorized into a single table.

Results: The majority of studies indicated the presence of an abnormal vitelline artery. Other angiographic findings concerned variations of the ileal and the iliac arteries. However, the literature revealed the presence of vascular variations without the existence of Meckel's Diverticulum, whereas a remnant of the vitelline vein may be present, but it is very rare.

Conclusion: The detection of vascular variations accompanying Meckel's Diverticulum is not always easy and requires the correct choice of imaging method to prevent misdiagnosis.

目的:本研究的目的是描述在梅克尔憩室患者中观察到的血管解剖变异。方法:通过PubMed数据库进行文献综述,使用术语:“Meckel憩室与血管”,“Meckel憩室与解剖变异”和“Meckel憩室变异”。正常解剖也使用经典解剖学教科书。其他文章提供了与本综述目的相关的有用信息。因此,我们将符合纳入标准的文章纳入本综述,并将收集到的数据分类成一个表。结果:多数研究表明存在异常卵黄动脉。其他血管造影结果涉及回肠和髂动脉的变化。然而,文献显示存在血管变异而不存在梅克尔憩室,而卵黄静脉的残余可能存在,但这是非常罕见的。结论:梅克尔憩室伴发血管变异的检测并不容易,需要正确选择影像学方法,防止误诊。
{"title":"Anatomical Variations of Vascular Anatomy in Meckel's Diverticulum.","authors":"Dimitrios Malligiannis Ntalianis,&nbsp;Rami N Maloula,&nbsp;Konstantinos Malligiannis Ntalianis,&nbsp;Panagiotis Giavopoulos,&nbsp;Eirini Solia,&nbsp;Dimosthenis Chrysikos,&nbsp;Vasileios Karampelias,&nbsp;Theodore Troupis","doi":"10.5644/ama2006-124.394","DOIUrl":"https://doi.org/10.5644/ama2006-124.394","url":null,"abstract":"<p><strong>Objective: </strong>The objective of the current study was to describe the anatomical variations of vessels observed in patients with Meckel's Diverticulum.</p><p><strong>Methods: </strong>A narrative review of the literature was undertaken by means of the PubMed database, using the terms: \"Meckel's Diverticulum AND vessels\", \"Meckel's Diverticulum AND anatomical variation\" and \"Meckel's Diverticulum variation\". Classical anatomical textbooks were also used for normal anatomy. Additional articles provided useful information in relation to the aim of this review. Hence, the articles that met the inclusion criteria were included in this review, and the collected data were categorized into a single table.</p><p><strong>Results: </strong>The majority of studies indicated the presence of an abnormal vitelline artery. Other angiographic findings concerned variations of the ileal and the iliac arteries. However, the literature revealed the presence of vascular variations without the existence of Meckel's Diverticulum, whereas a remnant of the vitelline vein may be present, but it is very rare.</p><p><strong>Conclusion: </strong>The detection of vascular variations accompanying Meckel's Diverticulum is not always easy and requires the correct choice of imaging method to prevent misdiagnosis.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"51 3","pages":"243-248"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/55/8f/AMA-51-243.PMC10116170.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9389036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Remarkably Rare Position of a Cutaneous Ciliated Cyst in a 16 Month-old Female: A Case Report. 一个非常罕见的位置皮肤纤毛囊肿在一个16个月大的女性:一个病例报告。
Q3 Medicine Pub Date : 2022-12-01 DOI: 10.5644/ama2006-124.390
Michail Anastasakis, Ioanna Gkalonaki, Charalampos Doitsidis, Ioannis Patoulias

Objective: The aim of the work was to show a Cutaneous Ciliated Cyst (CCC) in an unusual location in a 16-month-old girl.

Case report: We present the case of a 16-month otherwise healthy girl presented to our hospital, with a report of a palpable mass in the left suprascapular region. Physical examination revealed a soft-textured, fluctuating, mobile and painless entity, with no further indications of local inflammation. The mass was totally excised, under general anesthesia, for both diagnostic and therapeutic purposes. According to the histopathological findings, the cystic lesion was covered by a pseudostratified ciliary epithelium, resembling the epithelium of a normal fallopian tube, surrounded by a smooth muscle layer. Immunohistochemical studies identified the cyst epithelium as having cytokeratin (CKAE1/AE3) expression, despite the negative immunostaining findings on Estrogen and Progesterone Receptors.

Conclusion: Our case report concerns a CCC in an unusual position, in the suprascapular area. After a thorough review of the international literature, we concluded that this is the second published case regarding this specific location. To our knowledge our patient is the youngest ever diagnosed with CCC.

目的:工作的目的是显示皮肤纤毛囊肿(CCC)在一个不寻常的位置在一个16个月大的女孩。病例报告:我们提出的情况下,16个月健康的女孩提出了我们的医院,报告可触及的肿块在左侧肩胛上区域。体格检查显示一个质地柔软、上下波动、可移动、无痛的实体,没有进一步的局部炎症迹象。为了诊断和治疗目的,在全身麻醉下完全切除肿块。根据组织病理学结果,囊性病变被假层状纤毛上皮覆盖,类似于正常输卵管的上皮,被平滑肌层包围。免疫组化研究发现囊肿上皮细胞角蛋白(CKAE1/AE3)表达,尽管雌激素和孕激素受体免疫染色结果为阴性。结论:我们的病例报告涉及一个不寻常的位置,在肩胛上区域的CCC。在对国际文献进行全面回顾后,我们得出结论,这是关于该特定地点的第二个已发表的病例。据我们所知,这位患者是有史以来最年轻的CCC确诊患者。
{"title":"A Remarkably Rare Position of a Cutaneous Ciliated Cyst in a 16 Month-old Female: A Case Report.","authors":"Michail Anastasakis,&nbsp;Ioanna Gkalonaki,&nbsp;Charalampos Doitsidis,&nbsp;Ioannis Patoulias","doi":"10.5644/ama2006-124.390","DOIUrl":"https://doi.org/10.5644/ama2006-124.390","url":null,"abstract":"<p><strong>Objective: </strong>The aim of the work was to show a Cutaneous Ciliated Cyst (CCC) in an unusual location in a 16-month-old girl.</p><p><strong>Case report: </strong>We present the case of a 16-month otherwise healthy girl presented to our hospital, with a report of a palpable mass in the left suprascapular region. Physical examination revealed a soft-textured, fluctuating, mobile and painless entity, with no further indications of local inflammation. The mass was totally excised, under general anesthesia, for both diagnostic and therapeutic purposes. According to the histopathological findings, the cystic lesion was covered by a pseudostratified ciliary epithelium, resembling the epithelium of a normal fallopian tube, surrounded by a smooth muscle layer. Immunohistochemical studies identified the cyst epithelium as having cytokeratin (CKAE1/AE3) expression, despite the negative immunostaining findings on Estrogen and Progesterone Receptors.</p><p><strong>Conclusion: </strong>Our case report concerns a CCC in an unusual position, in the suprascapular area. After a thorough review of the international literature, we concluded that this is the second published case regarding this specific location. To our knowledge our patient is the youngest ever diagnosed with CCC.</p>","PeriodicalId":38313,"journal":{"name":"Acta medica academica","volume":"51 3","pages":"209-211"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/26/a6/AMA-51-209.PMC10116175.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9389035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta medica academica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1